NCT06290193View on ClinicalTrials.gov

Study of Acute Normovolemic Hemodilution (ANH) in People With Ovarian Cancer Who Are Having Cytoreductive Surgery

PHASE2RecruitingINTERVENTIONAL
Enrollment

86

Participants

Timeline

Start Date

February 23, 2024

Primary Completion Date

February 23, 2029

Study Completion Date

February 23, 2029

Conditions
Ovarian CancerFallopian Tube CarcinomaOvarian CarcinomaPeritoneal CarcinomaOvarian Cancer Stage IIICFallopian Tube Cancer Stage IIICOvarian Cancer Stage IVFallopian Tube Cancer Stage IVFallopian Tube CancerPeritoneal Cancer
Interventions
BIOLOGICAL

Acute Normovolemic Hemodilution/ANH

For participants randomized to ANH, the volume of blood to be removed will be calculated using an established formula, based on preoperative hemoglobin, target hemoglobin after hemodilution, and the patient's estimated blood volume.

Trial Locations (7)

10065

RECRUITING

Memorial Sloan Kettering Cancer Center (All protocol activities), New York

10604

RECRUITING

Memorial Sloan Kettering Westchester (Limited protocol activities), Harrison

11553

RECRUITING

Memorial Sloan Kettering Nassau (Limited Protocol Activities), Uniondale

11725

RECRUITING

Memorial Sloan Kettering Cancer Center @ Suffolk-Commack (Limited protocol activities), Commack

07920

RECRUITING

Memoral Sloan Kettering at Basking Ridge (Limited Protocol Activities), Basking Ridge

07748

RECRUITING

Memorial Sloan Kettering Monmouth (Limited protocol activities), Middletown

07645

RECRUITING

Memorial Sloan Kettering Bergen (Limited protocol activities), Montvale

All Listed Sponsors
lead

Memorial Sloan Kettering Cancer Center

OTHER